Banzai International (BNZI) said Tuesday its lenders and service providers agreed to write off up to $5.6 million of outstanding liabilities and restructure $19.2 million of existing debt obligations.
Shares almost doubled as intraday trading volume soared to over 51.6 million from a daily average of about 1.05 million.
Seelos Therapeutics (SEEL) said Tuesday its SLS-002 was selected for inclusion in the US Department of Defense's Military and Veterans Adaptive Platform Clinical Trial to evaluate its potential for treatment of post-traumatic stress disorder.
Shares surged 81% as intraday trading volume climbed to more than 308 million from a daily average of about 2.04 million.
Wave Life Sciences (WVE) shares soared 50% after the company reported Tuesday "positive" interim data from a phase 2 trial of WVE-N531 to treat boys with Duchenne muscular dystrophy who are amenable to exon 53 skipping.
More than 11.7 million shares were traded intraday, compared with a daily average of about 897,000.
Price: 8.14, Change: +3.94, Percent Change: +93.69
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。